RYMAX | VTCAX | RYMAX / VTCAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 20 years | - |
Gain YTD | 18.745 | 37.607 | 50% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | 1000 | N/A | - |
Net Assets | 31.3M | 4.64B | 1% |
Annual Yield % from dividends | 1.82 | 0.94 | 192% |
Returns for 1 year | 20.73 | 39.82 | 52% |
Returns for 3 years | -4.59 | 21.85 | -21% |
Returns for 5 years | 12.52 | 72.50 | 17% |
Returns for 10 years | 29.32 | 92.70 | 32% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFIX | 12.93 | 0.02 | +0.15% |
AlphaCentric Life Sciences & Hlthcare I | |||
FSERX | 19.29 | -0.07 | -0.36% |
Franklin Real Estate Securities R6 | |||
EQTIX | 17.92 | -0.09 | -0.50% |
Shelton Equity Income Investor | |||
PRIAX | 26.48 | -0.18 | -0.68% |
Principal Glb Emerging Markets A | |||
ERASX | 43.53 | -0.46 | -1.05% |
Eaton Vance Atlanta Capital SMID-Cap R6 |